Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12613000862741
ACTRN12613000862741
Not yet recruiting
Phase 4

In critically ill patients infected with extensively drug resistant Acinetobacter baumanii (XDRAb), does the use of colistin loading dose compared to the normal maintenance of colistin has better 30 day mortality outcome?

Helmi B Sulaiman0 sites100 target enrollmentAugust 5, 2013
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Helmi B Sulaiman
Enrollment
100
Status
Not yet recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 5, 2013
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Helmi B Sulaiman

Eligibility Criteria

Inclusion Criteria

  • •1\)Age 18 and above
  • •2\)Patients with a first episode of culture proven XDRAb from blood, CSF, sputum and tracheal aspirate samples.
  • •3\)Receive colistin treatment for more than 72 hours
  • •4\)Fulfill diagnostic criteria for ventilator\-related pneumonia, hospital\-acquired pneumonia, bacteremia (catheter\- and non catheter\-related), and meningitis or CSF infections, as defined in accordance with IDSA guidelines

Exclusion Criteria

  • •1\) Pregnant
  • •2\) Breastfeeding
  • •3\) ALT/AST more than 8 times upper limit of normal
  • •5\) Allergy to colistin or its prodrug

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A retrospective review on the use of Regional citrate Anticoagulation (RCA) in Continuous Venovenous Hemofiltration (CVVH) for critically ill patients
ACTRN12611000360910Dr Anne Leung30
Not yet recruiting
Not Applicable
An observational study to assess complications in critically ill patients during transport within the hospital to and from ICU.Health Condition 1: 4- Measurement and Monitoring
CTRI/2024/07/071056Department of Anaesthesiology and Critical Care JNMCH AM
Not yet recruiting
Not Applicable
Occurence and outcome of sick patients with COVID 19 and new kidney disease.Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
CTRI/2021/11/037973SMS medical college and hospital
Completed
Phase 2
Pilot randomised controlled trial of continuous beta-lactam infusion compared with intermittent dosing in critically ill patients
ACTRN12610000238077Beta-Lactam Infusion Group60
Not yet recruiting
Not Applicable
The effects of Posture and Continuous Positive Airway Pressure (CPAP) on lung function in patients recovering from an acute exacerbation of heart failureHeart FailureCardiovascular - Other cardiovascular diseasesRespiratory - Other respiratory disorders / diseases
ACTRN12610000556044Professor Matthew Naughton100